Resveratrol-Elicited PKC Inhibition Counteracts NOX-Mediated Endothelial to Mesenchymal Transition in Human Retinal Endothelial Cells Exposed to High Glucose

Diabetes-associated long-term hyperglycaemia leads to oxidative stress-mediated fibrosis in different tissues and organs. Endothelial-to-mesenchymal-transition (EndMT) appears to play a role in diabetes-associated fibrotic conditions. Here, we investigate whether EndMT is implicated in the diabetic...

ver descrição completa

Detalhes bibliográficos
Principais autores: Roberta Giordo, Gheyath K. Nasrallah, Anna Maria Posadino, Francesco Galimi, Giampiero Capobianco, Ali Hussein Eid, Gianfranco Pintus
Formato: Artigo
Idioma:English
Publicado em: MDPI AG 2021-02-01
coleção:Antioxidants
Assuntos:
Acesso em linha:https://www.mdpi.com/2076-3921/10/2/224
_version_ 1827604557517029376
author Roberta Giordo
Gheyath K. Nasrallah
Anna Maria Posadino
Francesco Galimi
Giampiero Capobianco
Ali Hussein Eid
Gianfranco Pintus
author_facet Roberta Giordo
Gheyath K. Nasrallah
Anna Maria Posadino
Francesco Galimi
Giampiero Capobianco
Ali Hussein Eid
Gianfranco Pintus
author_sort Roberta Giordo
collection DOAJ
description Diabetes-associated long-term hyperglycaemia leads to oxidative stress-mediated fibrosis in different tissues and organs. Endothelial-to-mesenchymal-transition (EndMT) appears to play a role in diabetes-associated fibrotic conditions. Here, we investigate whether EndMT is implicated in the diabetic retinopathy fibrotic process and evaluate the possibility that resveratrol could counteract EndMT by inhibiting high glucose (HG)-induced increases in ROS. Primary Human Retinal Endothelial Cells (HRECs) were either pre-treated for 24 h with 1 µM resveratrol or left untreated, then glucose (30 mM) was applied at 3-day intervals for 10 days. qRT-PCR and ELISA were used to detect mRNA or protein expression of endothelial markers (CD31, CDH5, vWF) or mesenchymal markers (VIM, αSMA and collagen I), respectively. Intracellular ROS levels were measured with carboxy-DCFDA, while NOX-associated ROS levels were evaluated using the NADPH-specific redox biosensor p47-roGFP. Treatment of HRECs with HG increased intracellular ROS levels and promoted phenotype shifting towards EndMT, evidenced by decreased expression of endothelial markers concomitant with increased expression of mesenchymal ones. HG-induced EndMT appears to be mediated by NADPH-associated ROS generation as pre-treatment of HRECs with resveratrol or the NADPH inhibitor, diphenyleneiodonium chloride (DPI), attenuated ROS production and EndMT transition, suggesting that the effect of resveratrol on HG-induced ROS occurs via down-regulation of NADPH oxidase. It is worth noting that resveratrol or Chelerythrine, a Protein kinase C (PKC) inhibitor, reduce ROS and EndMT in HG-exposed cells, suggesting that NADPH activation occurs via a PKC-dependent mechanism. Taken together, our results provide the basis for a resveratrol-based potential protective therapy to prevent diabetic-associated complications.
first_indexed 2024-03-09T06:01:47Z
format Article
id doaj.art-e88f00905f394ca4b0ace3b17d5a8dd5
institution Directory Open Access Journal
issn 2076-3921
language English
last_indexed 2024-03-09T06:01:47Z
publishDate 2021-02-01
publisher MDPI AG
record_format Article
series Antioxidants
spelling doaj.art-e88f00905f394ca4b0ace3b17d5a8dd52023-12-03T12:08:36ZengMDPI AGAntioxidants2076-39212021-02-0110222410.3390/antiox10020224Resveratrol-Elicited PKC Inhibition Counteracts NOX-Mediated Endothelial to Mesenchymal Transition in Human Retinal Endothelial Cells Exposed to High GlucoseRoberta Giordo0Gheyath K. Nasrallah1Anna Maria Posadino2Francesco Galimi3Giampiero Capobianco4Ali Hussein Eid5Gianfranco Pintus6Department of Medical Laboratory Sciences, College of Health Sciences and Sharjah Institute for Medical Research, University of Sharjah, Sharjah 27272, UAEDepartment of Biomedical Sciences, College of Health Sciences Member of QU Health, Qatar University, Doha 2713, QatarDepartment of Biomedical Sciences, University of Sassari, 07100 Sassari, ItalyDepartment of Biomedical Sciences, University of Sassari, 07100 Sassari, ItalyGynecologic and Obstetric Clinic, Department of Medical, Surgical and Experimental Sciences, University of Sassari, 07100 Sassari, ItalyDepartment of Basic Medical Sciences, College of Medicine, QU Health, Qatar University, Doha 2713, QatarDepartment of Medical Laboratory Sciences, College of Health Sciences and Sharjah Institute for Medical Research, University of Sharjah, Sharjah 27272, UAEDiabetes-associated long-term hyperglycaemia leads to oxidative stress-mediated fibrosis in different tissues and organs. Endothelial-to-mesenchymal-transition (EndMT) appears to play a role in diabetes-associated fibrotic conditions. Here, we investigate whether EndMT is implicated in the diabetic retinopathy fibrotic process and evaluate the possibility that resveratrol could counteract EndMT by inhibiting high glucose (HG)-induced increases in ROS. Primary Human Retinal Endothelial Cells (HRECs) were either pre-treated for 24 h with 1 µM resveratrol or left untreated, then glucose (30 mM) was applied at 3-day intervals for 10 days. qRT-PCR and ELISA were used to detect mRNA or protein expression of endothelial markers (CD31, CDH5, vWF) or mesenchymal markers (VIM, αSMA and collagen I), respectively. Intracellular ROS levels were measured with carboxy-DCFDA, while NOX-associated ROS levels were evaluated using the NADPH-specific redox biosensor p47-roGFP. Treatment of HRECs with HG increased intracellular ROS levels and promoted phenotype shifting towards EndMT, evidenced by decreased expression of endothelial markers concomitant with increased expression of mesenchymal ones. HG-induced EndMT appears to be mediated by NADPH-associated ROS generation as pre-treatment of HRECs with resveratrol or the NADPH inhibitor, diphenyleneiodonium chloride (DPI), attenuated ROS production and EndMT transition, suggesting that the effect of resveratrol on HG-induced ROS occurs via down-regulation of NADPH oxidase. It is worth noting that resveratrol or Chelerythrine, a Protein kinase C (PKC) inhibitor, reduce ROS and EndMT in HG-exposed cells, suggesting that NADPH activation occurs via a PKC-dependent mechanism. Taken together, our results provide the basis for a resveratrol-based potential protective therapy to prevent diabetic-associated complications.https://www.mdpi.com/2076-3921/10/2/224resveratroldiabetesfibrosisNOXoxidative stressEndMT
spellingShingle Roberta Giordo
Gheyath K. Nasrallah
Anna Maria Posadino
Francesco Galimi
Giampiero Capobianco
Ali Hussein Eid
Gianfranco Pintus
Resveratrol-Elicited PKC Inhibition Counteracts NOX-Mediated Endothelial to Mesenchymal Transition in Human Retinal Endothelial Cells Exposed to High Glucose
Antioxidants
resveratrol
diabetes
fibrosis
NOX
oxidative stress
EndMT
title Resveratrol-Elicited PKC Inhibition Counteracts NOX-Mediated Endothelial to Mesenchymal Transition in Human Retinal Endothelial Cells Exposed to High Glucose
title_full Resveratrol-Elicited PKC Inhibition Counteracts NOX-Mediated Endothelial to Mesenchymal Transition in Human Retinal Endothelial Cells Exposed to High Glucose
title_fullStr Resveratrol-Elicited PKC Inhibition Counteracts NOX-Mediated Endothelial to Mesenchymal Transition in Human Retinal Endothelial Cells Exposed to High Glucose
title_full_unstemmed Resveratrol-Elicited PKC Inhibition Counteracts NOX-Mediated Endothelial to Mesenchymal Transition in Human Retinal Endothelial Cells Exposed to High Glucose
title_short Resveratrol-Elicited PKC Inhibition Counteracts NOX-Mediated Endothelial to Mesenchymal Transition in Human Retinal Endothelial Cells Exposed to High Glucose
title_sort resveratrol elicited pkc inhibition counteracts nox mediated endothelial to mesenchymal transition in human retinal endothelial cells exposed to high glucose
topic resveratrol
diabetes
fibrosis
NOX
oxidative stress
EndMT
url https://www.mdpi.com/2076-3921/10/2/224
work_keys_str_mv AT robertagiordo resveratrolelicitedpkcinhibitioncounteractsnoxmediatedendothelialtomesenchymaltransitioninhumanretinalendothelialcellsexposedtohighglucose
AT gheyathknasrallah resveratrolelicitedpkcinhibitioncounteractsnoxmediatedendothelialtomesenchymaltransitioninhumanretinalendothelialcellsexposedtohighglucose
AT annamariaposadino resveratrolelicitedpkcinhibitioncounteractsnoxmediatedendothelialtomesenchymaltransitioninhumanretinalendothelialcellsexposedtohighglucose
AT francescogalimi resveratrolelicitedpkcinhibitioncounteractsnoxmediatedendothelialtomesenchymaltransitioninhumanretinalendothelialcellsexposedtohighglucose
AT giampierocapobianco resveratrolelicitedpkcinhibitioncounteractsnoxmediatedendothelialtomesenchymaltransitioninhumanretinalendothelialcellsexposedtohighglucose
AT alihusseineid resveratrolelicitedpkcinhibitioncounteractsnoxmediatedendothelialtomesenchymaltransitioninhumanretinalendothelialcellsexposedtohighglucose
AT gianfrancopintus resveratrolelicitedpkcinhibitioncounteractsnoxmediatedendothelialtomesenchymaltransitioninhumanretinalendothelialcellsexposedtohighglucose